Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis
- 1 January 2000
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 42 (1) , 70-75
- https://doi.org/10.1016/s0190-9622(00)90011-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosisJournal of the American Academy of Dermatology, 1995
- Autoantibodies to pyruvate dehydrogenase complex in patients with systemic sclerosisArthritis & Rheumatism, 1995
- Serum metalloproteinases and their inhibitors: markers for malignant potentialBritish Journal of Cancer, 1994
- Decreased Collagenase Expression in Cultured Systemic Sclerosis FibroblastsJournal of Investigative Dermatology, 1994
- Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity.Annals of the Rheumatic Diseases, 1993
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991
- Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases An application for rheumatoid arthritis serum and plasmaJournal of Immunological Methods, 1990
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- Increased Collagen Synthesis by Scleroderma Skin Fibroblasts In Vitro A POSSIBLE DEFECT IN THE REGULATION OR ACTIVATION OF THE SCLERODERMA FIBROBLASTJournal of Clinical Investigation, 1974